Evidence map›Paper›PMID 40427906›Full record

ReviewInternational journal of environmental research and public health2025

E-Cigarette or Vaping Product Use-Associated Lung Injury: A Comprehensive Review.

Mohammad Asim Amjad, Daniel Ocazionez Trujillo, Rosa M Estrada-Y-Martin, Sujith V Cherian

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Vaping-related lung disease: a narrative review.Journal of thoracic disease · 2026
    Review
  4. Article
  5. Spirometric Lung Function Among Smokers and Non-Smokers: A Cross-Sectional Study in University Students.International journal of environmental research and public health · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad Asim AmjadDivisions of Critical Care, Pulmonary and Sleep Medicine, Department of Internal Medicine, University of Texas Health-McGovern Medical School, 6431 Fannin Street, MSB 1.434, Houston, TX 77030, USA.
Daniel Ocazionez TrujilloDepartment of Diagnostic and Interventional Imaging, University of Texas Health-McGovern Medical School, Houston, TX 77030, USA.
Rosa M Estrada-Y-MartinDivisions of Critical Care, Pulmonary and Sleep Medicine, Department of Internal Medicine, University of Texas Health-McGovern Medical School, 6431 Fannin Street, MSB 1.434, Houston, TX 77030, USA.ORCID 0000-0003-4323-2410
Sujith V CherianDivisions of Critical Care, Pulmonary and Sleep Medicine, Department of Internal Medicine, University of Texas Health-McGovern Medical School, 6431 Fannin Street, MSB 1.434, Houston, TX 77030, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E-cigarette or vaping product use-associated lung injury (EVALI) is a critical and potentially fatal form of lung injury that gained considerable public health concern in 2019. The use of e-cigarettes and vaping products is causally associated with EVALI, a condition characterized by a constellation of respiratory symptoms, such as coughing, shortness of breath, and chest pain. This comprehensive narrative literature review explores the complexities of EVALI, including its association with the structure and composition of e-cigarettes and its epidemiology, pathogenesis, clinical and radiological manifestations, management strategies, and public health implications. Moreover, it uncovers the long-term repercussions of EVALI and underscores the ongoing research endeavors designed to mitigate and comprehend the risks associated with using e-cigarettes.

Indexed as

Electronic Nicotine Delivery SystemsLung InjuryVapingHumansARDSe-cigaretteselectronic cigarette or vaping product-associated lung injuryhypoxemic respiratory failure

Identifiers

PMID40427906
PMCPMC12111167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.